Market Closed -
Sao Paulo
21:07:48 03/05/2024 BST
5-day change
1st Jan Change
10.53
BRL
+1.87%
-2.41%
-35.83%
Sales 2024 *
1.6B
315M
25.13B
Sales 2025 *
1.79B
354M
28.2B
Capitalization
1.87B
369M
29.41B
Net income 2024 *
199M
39.27M
3.13B
Net income 2025 *
260M
51.31M
4.09B
EV / Sales 2024 *
1.36
x
Net Debt
2024
*
302M
59.57M
4.75B
Net Debt
2025
*
375M
73.98M
5.89B
EV / Sales 2025 *
1.25
x P/E ratio 2024 *
9.01
x
P/E ratio 2025 *
7.48
x
Employees
1,900
Yield 2024 *
2.67%
Yield 2025 *
3.2%
Free-Float
16.44%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Transcript : Blau Farmacêutica S.A., Q4 2023 Earnings Call, Mar 20, 2024
03-20
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
03-18
CI
Transcript : Blau Farmacêutica S.A., Q3 2023 Earnings Call, Nov 09, 2023
11-09
Blau Farmacêutica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-09
CI
Transcript : Blau Farmacêutica S.A., Q2 2023 Earnings Call, Aug 10, 2023
10/08/23
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
10/08/23
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
08/08/23
CI
Blau Farmacêutica S.A. completed the acquisition of Laboratorio Quimico Farmaceutico Bergamo Ltda from Amgen Inc. for $33.2 million.
29/06/23
CI
Transcript : Blau Farmacêutica S.A., Q1 2023 Earnings Call, May 05, 2023
05/05/23
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
04/05/23
CI
Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
03/05/23
CI
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
02/03/23
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
01/03/23
CI
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
02/11/22
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
02/11/22
CI
More news
1 day +1.87%
1 week -2.41%
Current month +4.57%
1 month -13.62%
3 months -11.06%
6 months -37.13%
Current year -35.83%
More quotes
Managers
Title Age Since
Founder
-
17/12/87
Director of Finance/CFO
-
30/04/18
Compliance Officer
-
31/12/13
Members of the board
Title Age Since
Director/Board Member
61
-
Chief Operating Officer
58
-
Founder
-
17/12/87
More insiders
Date
Price
Change
Volume
03/05/24
10.53
+3.03%
387,600
02/05/24
10.22
+1.49%
369,300
30/04/24
10.07
-5.45%
1,501,900
29/04/24
10.65
-1.30%
312,700
26/04/24
10.79
+5.78%
359,700
Delayed Quote
Sao Paulo, May 03, 2024 at 09:07 pm
More quotes
Blau Farmaceutica SA is a Brazil-based company engaged in the pharmaceuticals sector. The Company focuses on the development, production and commercialization of medicines, which aim at treatment in the areas of oncology, nephrology, hematology and infectology, among others. Its product lines includes biopharmaceuticals, biosimilars, oncological - injectable, oncological - oral, blood products, antiviral and antiretrovirals, uterine stimulators, anaesthetics, antithrombotics, thrombolytics, female health care, antibiotics, non-beta lactams, cephalosporin, chloramphenicol, acid pumper inhibitor and other hospital products. The Company operates in Brazil, Argentina, Colombia, Peru, Uruguay, Chile and the United States, having a pharmaceutical industrial complex composed of five industrial plants, dedicated to the production of biological, biotechnological and oncological medicines, antibiotics, injectable anesthetics and biotechnological inputs.
More about the company
Mean consensus
UNDERPERFORM
Last Close Price
10.53
BRL
Average target price
13.57
BRL
Spread / Average Target
+28.88%
Consensus
1st Jan change
Capi.
-35.83% 369M +21.85% 546B -4.77% 359B +16.97% 323B +5.69% 290B +13.68% 234B +3.65% 198B -11.12% 194B +8.08% 167B -3.40% 157B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1